Methotrexate as a safe immunosuppressive agent during the COVID-19 pandemic

BACKGROUND: During the ongoing COVID-19 pandemic, immunocompromised patients are at a higher risk of severe infection, since the immune system has an important role in defeating this disease. This study compares the severity of COVID-19 in patients taking methotrexate with the severity of their fami...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganjei, Zakiye, Faraji Dana, Hoorvash, Ebrahimi-Dehkordi, Sepehr, Alidoust, Fereshte, Bahmani, Kiumars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556580/
https://www.ncbi.nlm.nih.gov/pubmed/34731780
http://dx.doi.org/10.1016/j.intimp.2021.108324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556580/
https://www.ncbi.nlm.nih.gov/pubmed/34731780
http://dx.doi.org/10.1016/j.intimp.2021.108324

Ejemplares similares